Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma (Q80224586)

From Wikidata

Jump to navigation Jump to search

scientific article published on 07 September 2006

edit

Language	Label	Description	Also known as
English	Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma	scientific article published on 07 September 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

title

Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

main subject

phase II clinical trial

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Margaret Tempero

series ordinal

6

object named as

Margaret Tempero

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

author name string

Minaxi Jhawer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Lee Rosen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Janet Dancey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Howard Hochster

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Solomon Hamburg

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Neil Clendeninn

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Sridhar Mani

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

publication date

7 September 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

published in

Investigational New Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

volume

25

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

page(s)

85-94

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

cites work

How large should a phase II trial of a new drug be?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin therapy in American patients with hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival probabilities (the Kaplan-Meier method).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous in

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: the need for progress.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16957834

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10637-006-9003-X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Dimensions Publication ID

1044368143

0 references

PubMed publication ID

16957834

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16957834

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16957834%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80224586&oldid=2222837856"